<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>CD34++ cells from 45 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) were observed by flow cytometry for the expression of granulocyte colony-stimulating factor receptor (G-CSFR) </plain></SENT>
<SENT sid="1" pm="."><plain>Ten patients had a significantly reduced expression of G-CSFR </plain></SENT>
<SENT sid="2" pm="."><plain>Late stages of disease showed a higher proportion of either high or low G-CSFR expression than earlier stages </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> (RA), G-CSFR was inversely related to CD33 expression </plain></SENT>
<SENT sid="4" pm="."><plain>Most patients (9/10) with low G-CSFR expression had <z:hpo ids='HP_0001875'>neutropenia</z:hpo> of the peripheral blood </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001875'>Neutropenia</z:hpo> was less common in the <z:mpath ids='MPATH_458'>normal</z:mpath> group, but also occurred in the high expression group </plain></SENT>
<SENT sid="6" pm="."><plain>No neutrophil response was observed following G-CSF administration to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients (6/6) with low G-CSFR expression </plain></SENT>
<SENT sid="7" pm="."><plain>In the high expression group, patients (3/3) showed a response to G-CSF while, in the <z:mpath ids='MPATH_458'>normal</z:mpath> group (1/2), the response was minor </plain></SENT>
<SENT sid="8" pm="."><plain>In the <z:mpath ids='MPATH_458'>normal</z:mpath>- or high-receptor-expressing groups, the receptors were functionally active in terms of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> but not proliferation and clonogenic growth, although no clear correlation to receptor expression was observed </plain></SENT>
<SENT sid="9" pm="."><plain>The G-CSFR signal transduction pathway in the <z:mpath ids='MPATH_458'>normal</z:mpath> and high group was not deficient of <z:chebi fb="5" ids="33699">messenger RNA</z:chebi> for either janus kinases (Jaks) or signal transducers and activators of transcription (Stats) </plain></SENT>
<SENT sid="10" pm="."><plain>These findings suggest that the lowered expression of G-CSFR may cause <z:hpo ids='HP_0001875'>neutropenia</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients and, therefore, may partially explain the <z:hpo ids='HP_0001875'>neutropenia</z:hpo> in myelodysplastic patients </plain></SENT>
</text></document>